| 发明名称 |
CB2 RECEPTOR LIGANDS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS |
| 摘要 |
The present invention provides cannabinoid type 2 (CB2) receptor inverse agonists for treating or ameliorating psychiatric disorders. The present invention further provides pharmaceutical compositions comprising 4′-O-methylhonokiol for treating Attention Deficit Hyperactivity Disorder (ADHD) and Tourette's syndrome. |
| 申请公布号 |
EP2986587(A1) |
申请公布日期 |
2016.02.24 |
| 申请号 |
EP20140785401 |
申请日期 |
2014.04.16 |
| 申请人 |
ARIEL - UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY, LTD. |
发明人 |
ANAVI-GOFFER, SHARON;GERTSCH, JUERG |
| 分类号 |
C07C39/21;A61K31/05;A61P5/30;A61P25/00;A61P25/20 |
主分类号 |
C07C39/21 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
